Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis

被引:53
作者
Yang, Baojuan [1 ]
Zhu, Lin [2 ]
Cheng, Haiyan [1 ]
Li, Qi [1 ]
Zhang, Yunyan [1 ]
Zhao, Yashuang [2 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Gynecol Oncol, Harbin, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China
关键词
IMRT; 3D-CRT; DVH; Gynecologic malignancies; Meta-analysis; WHOLE PELVIC RADIOTHERAPY; ACUTE HEMATOLOGIC TOXICITY; ADVANCED CERVICAL-CANCER; RADIATION-THERAPY; CONCURRENT CISPLATIN; PROSTATE-CANCER; BONE-MARROW; GASTROINTESTINAL TOXICITY; DOSE-ESCALATION; EXTENDED-FIELD;
D O I
10.1186/1748-717X-7-197
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To quantitatively evaluate the safety and related-toxicities of intensity modulated radiotherapy (IMRT) dose-volume histograms (DVHs), as compared to the conventional three-dimensional conformal radiotherapy (3D-CRT), in gynecologic malignancy patients by systematic review of the related publications and meta-analysis. Methods: Relevant articles were retrieved from the PubMed, Embase, and Cochrane Library databases up to August 2011. Two independent reviewers assessed the included studies and extracted data. Pooled average percent irradiated volumes of adjacent non-cancerous tissues were calculated and compared between IMRT and 3D-CRT for a range of common radiation doses (5-45Gy). Results: In total, 13 articles comprised of 222 IMRT-treated and 233 3D-CRT-treated patients were included. For rectum receiving doses >= 30 Gy, the IMRT pooled average irradiated volumes were less than those from 3D-CRT by 26.40% (30 Gy, p = 0.004), 27.00% (35 Gy, p = 0.040), 37.30% (40 Gy, p = 0.006), and 39.50% (45 Gy, p = 0.002). Reduction in irradiated small bowel was also observed for IMRT-delivered 40 Gy and 45 Gy (by 17.80% (p = 0.043) and 17.30% (p = 0.012), respectively), as compared with 3D-CRT. However, there were no significant differences in the IMRT and 3D-CRT pooled average percent volumes of irradiated small bowel or rectum from lower doses, or in the bladder or bone marrow from any of the doses. IMRT-treated patients did not experience more severe acute or chronic toxicities than 3D-CRT-treated patients. Conclusions: IMRT-delivered high radiation dose produced significantly less average percent volumes of irradiated rectum and small bowel than 3D-CRT, but did not differentially affect the average percent volumes in the bladder and bone marrow.
引用
收藏
页数:11
相关论文
共 47 条
[1]   IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk [J].
Ahmed, RS ;
Kim, RY ;
Duan, J ;
Meleth, S ;
De Los Santos, JF ;
Fiveash, JB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02) :505-512
[2]  
[Anonymous], 2001, INT J RAD ONCOL BIOL, V51, P880
[3]   Cervix carcinomas: Place of intensity-modulated radiotherapy [J].
Barillot, I. .
CANCER RADIOTHERAPIE, 2009, 13 (6-7) :507-510
[4]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[5]   Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer [J].
Beriwal, Sushil ;
Gan, Gregory N. ;
Heron, Dwight E. ;
Selvaraj, Rai N. ;
Kim, Hayeon ;
Lalonde, Ron ;
Kelley, Joseph L. ;
Edwards, Robert P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01) :166-171
[6]   Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies [J].
Brixey, CJ ;
Roeske, JC ;
Lujan, AE ;
Yamada, SD ;
Rotmensch, J ;
Mundt, AJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1388-1396
[7]   Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond [J].
Bucci, MK ;
Bevan, A ;
Roach, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :117-134
[8]   Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensitymodulated pelvic radiotherapy: Comparison with conventional radiotherapy [J].
Chen, Miao-Fen ;
Tseng, Chih-Jen ;
Tseng, Ching-Cheng ;
Kuo, Yuen-Chun ;
Yu, Chun-Yen ;
Chen, Wen-Cheng .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05) :1438-1444
[9]   Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial [J].
Creutzberg, CL ;
van Putten, WLJ ;
Koper, PCM ;
Lybeert, MLM ;
Jobsen, JJ ;
Wárlám-Rodenhuis, CC ;
De Winter, KAJ ;
Lutgens, LCHW ;
van den Bergh, ACM ;
van de Steen-Banasik, E ;
Beerman, H ;
van Lent, M .
LANCET, 2000, 355 (9213) :1404-1411
[10]   Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma [J].
D'Souza, WD ;
Ahamad, AA ;
Iyer, RB ;
Salehpour, MR ;
Jhingran, A ;
Eifel, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04) :1062-1070